Creating advanced sensors to detect cancer spread
Developing multiplexed microenvironmental sensors for precision diagnostics of cancer metastasis
This study is working on new sensors that can spot signs of cancer spreading, especially for colorectal cancer, to help doctors diagnose it earlier and more accurately, ultimately aiming to improve treatment for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University (Charles River Campus) NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11042192 on NIH RePORTER |
What this research studies
This research focuses on developing innovative sensors that can identify specific biomarkers related to cancer metastasis, which is the spread of cancer from its original site. By analyzing changes in the microenvironment, such as alterations in the extracellular matrix and immune components, the researchers aim to create highly sensitive and specific diagnostic tools. These sensors will be engineered to detect proteolytic activities associated with metastatic colorectal cancer, allowing for earlier and more accurate diagnosis. The approach combines advanced biomolecular engineering with detailed analysis of cancer biology to improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with colorectal cancer who may be at risk of metastasis.
Not a fit: Patients with non-cancerous conditions or those whose cancer is already at an advanced stage may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection of cancer metastasis, improving treatment options and outcomes for patients.
How similar studies have performed: Previous research has shown promise in using biomolecular sensors for cancer diagnostics, indicating potential success for this novel approach.
Where this research is happening
Boston, United States
- Boston University (Charles River Campus) — Boston, United States (Active)
Researchers
- Principal investigator: Hao, Liangliang — Boston University (Charles River Campus)
- Study coordinator: Hao, Liangliang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.